Latest Bone density Stories

To fully optimize a drug therapy for osteoporosis and low bone mineral density (BMD), patients should maintain vitamin D levels above the limits recently recommended by the Institute of Medicine (IOM), according to a new study by researchers from Hospital for Special Surgery in New York. The study will be presented at the Endocrine Society's Annual Meeting in Boston, June 4-7.The study demonstrated that maintaining a circulating vitamin D level above 33 ng/ml is associated with a seven-fold...

A news study finds that the worse a woman's skin wrinkles are during the first few years of menopause, the lower her bone density is. The results will be presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston."In postmenopausal women the appearance of the skin may offer a glimpse of the skeletal well-being, a relationship not previously described," said Lubna Pal, MD, a reproductive endocrinologist and associate professor at Yale School of Medicine, New Haven,...

Patients with celiac disease are more than 4.5 times more likely to develop osteoporosis compared to healthy people in an age and gender matched cohort with no identifiable risk factors for osteoporosis, according to a study presented today at the EULAR 2011 Annual Congress.The British study of 1,030 people compares the extent of bone mineral density (BMD)* loss "“ a common measure of osteoporosis "“ in two physical locations in the body. The results demonstrated that the mean BMD of the...

ATLANTA, May 24, 2011 /PRNewswire/ -- Carol Donald is a vibrant, active 63-year-old woman who has been living with osteoporosis for over 10 years. With her bone density compromised, Carol suffered from a fracture in her spine when she was involved in a car accident earlier this year. (Photo: http://photos.prnewswire.com/prnh/20110524/NY07697 ) While conservative treatments were initially recommended, Carol found herself in excruciating pain every day for more than four weeks after the...

Women with osteoporosis in their hip suffer menopause two years earlier than healthy women, a study conducted at the University of Granada says. Additionally, although further study is required, researchers have found at least three genetic markers associated with osteoporosis in the hip in postmenopausal women.Osteoporosis in the hip increases the risk of suffering fractures, which is extremely disabling for the patient, and represents a high cost for the health public system. The aim of...

PHILADELPHIA, March 24, 2011 /PRNewswire/ -- Tarsa Therapeutics today announced that the Phase III ORACAL trial of its oral recombinant salmon calcitonin in the treatment of postmenopausal osteoporosis was successfully concluded and yielded statistically significant, positive top-line results. The results will be used to support a New Drug Application (NDA) submission to the Food and Drug Administration (FDA) targeted for the fourth quarter of 2011, based on the study design and specific...

THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new long-term data showing that during the fourth and fifth years of Prolia® (denosumab) treatment, postmenopausal women with osteoporosis receiving Prolia continued with further, statistically significant, year-over-year increases in lumbar spine and total hip bone mineral density (BMD), a key measurement of bone strength. The overall adverse event profile was similar for the fourth and fifth...

THOUSAND OAKS, Calif., March 23, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) today announced new data that showed postmenopausal women with osteoporosis had significantly greater adherence, compliance, and persistence during Prolia® (denosumab) treatment than during alendronate treatment, an oral bisphosphonate commonly used to treat osteoporosis. Adherence to treatment, which includes both compliance (a measure of how well patients follow directions for taking medication) and persistence...

By: Rhonda Craig, Ivanhoe Health Correspondent(Ivanhoe Newswire) -- The same medicines used to treat angina and chronic heart failure, may also help treat osteoporosis. In this new study, researchers found that postmenopausal women that used nitroglycerin ointment for two years experienced a modest increase in bone mineral density and decrease in bone loss.According to study authors, the number of osteoporotic fractures is increasing, and an inexpensive and widely available treatment like...

Older women who used bisphosphonates (medications that prevent loss of bone mass) for five years or more were more likely to experience "atypical" fractures involving the femoral shaft (bone in the leg that extends from the hip to the knee) or subtrochanteric (fractures in the bone just below the hip joint), compared to women with less usage. However, the absolute risk of these "atypical" fractures was low and bisphosphonate use was associated with a reduced risk of...